Page last updated: 2024-09-02

tamibarotene and cd 2019

tamibarotene has been researched along with cd 2019 in 1 studies

Compound Research Comparison

Studies (tamibarotene)	Trials (tamibarotene)	Recent Studies (post-2010) (tamibarotene)	Studies (cd 2019)	Trials (cd 2019)	Recent Studies (post-2010) (cd 2019)
198	10	105	12	0	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiba, H; Iba, K; Ishii, S; Mori, M; Nuka, S; Sawada, N	1

Other Studies

1 other study(ies) available for tamibarotene and cd 2019

Article	Year
All-trans retinoic acid inhibits dexamethasone-induced ALP activity and mineralization in human osteoblastic cell line SV HFO. Cell structure and function, 1997, Volume: 22, Issue:1 Topics: Alkaline Phosphatase; Benzoates; Biomarkers; Calcification, Physiologic; Cell Line; Dexamethasone; Enzyme Inhibitors; Humans; Naphthalenes; Osteoblasts; Osteocalcin; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoids; Teratogens; Tetrahydronaphthalenes; Tretinoin	1997

Article

Year

All-trans retinoic acid inhibits dexamethasone-induced ALP activity and mineralization in human osteoblastic cell line SV HFO.

Cell structure and function, 1997, Volume: 22, Issue:1

Topics: Alkaline Phosphatase; Benzoates; Biomarkers; Calcification, Physiologic; Cell Line; Dexamethasone; Enzyme Inhibitors; Humans; Naphthalenes; Osteoblasts; Osteocalcin; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoids; Teratogens; Tetrahydronaphthalenes; Tretinoin

1997